Short Cationic Peptides for Membrane Destabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antibacterial peptides are often long and difficult to synthesize, requiring complex processing and culture methods, which limits their economic manufacture and delivery options, and there is a growing need for shorter peptides that can effectively combat antibiotic-resistant bacterial strains.
Innovation Solution
Development of short cationic peptides with specific amino acid combinations, such as AA 1 -AA 2 -AA 1 -X-Y-Z, that exhibit antimicrobial activity through membrane destabilization, offering stability and low toxicity, and can be synthesized using conventional methods for broader application.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If long peptides (20 or more amino acids) are used to span bacterial cell membranes and form pores, then antimicrobial activity is achieved, but synthesis difficulty increases and manufacturing complexity worsens
Solution Approach 1:
The patent changes the critical parameter of peptide length from 20+ amino acids to just 3-5 amino acids, fundamentally altering the mechanism from pore formation to membrane destabilization. This parameter change enables both maintained antimicrobial activity and dramatically simplified synthesis
Solution Approach 2:
The invention extracts only the essential functional elements needed for antimicrobial activity (cationic charge and hydrophobic interaction capability) while removing the excessive length required for pore formation. The core antimicrobial function is preserved in a minimized peptide structure
2Reliability
If long peptides are used to ensure sufficient membrane-spanning length, then pore formation capability is achieved, but processing steps and cultural requirements increase
Solution Approach 1:
The patent changes the mechanism parameter from pore formation to membrane destabilization, allowing short peptides to achieve antimicrobial effect without complex processing. The peptides directly interact with and destabilize bacterial membranes through electrostatic and hydrophobic interactions
Solution Approach 2:
The invention uses simple, short-lived peptide structures that can be easily synthesized and discarded after use, replacing complex, stable pore-forming peptides. The short peptides achieve their function rapidly and do not require complex processing or purification
3Reliability
If conventional long peptides are used for antimicrobial therapy, then bacterial killing activity is achieved, but delivery options are limited requiring injection
Solution Approach 1:
The patent changes the peptide length parameter to enable alternative delivery routes. The short length allows absorption across nasal mucosa and other non-injectable routes, expanding administration options while maintaining bacterial killing activity through direct membrane interaction
4Reliability
If long peptides are synthesized to span cell membranes, then antimicrobial efficacy is achieved, but economic manufacture becomes difficult
Solution Approach 1:
The patent changes the economic parameter by reducing peptide length to 3-5 amino acids, enabling cost-effective synthesis through standard chemical methods. The short peptides can be manufactured economically while maintaining antimicrobial efficacy through their cationic and hydrophobic properties
Solution Approach 2:
The invention employs inexpensive, short peptide sequences that can be synthesized cheaply using standard chemical peptide synthesis methods, replacing expensive, complex long peptides. The simplicity of the sequences enables economical large-scale production
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These peptides demonstrate broad-spectrum antimicrobial activity, rapid bacterial killing, and resistance to enzymatic degradation, making them suitable for various therapeutic and agricultural uses, including topical administration and treatment of infections like onychomycosis.
Implementation Method 1
these peptides have a net positive charge and a propensity to form amphiphilic α-helix or β-sheet structures upon interaction with the outer phospholipid bilayer in bacterial cell membranes
Implementation Method 2
AA 2 is an amino acid with a large lipophilic R group selected from tributyl tryptophan (Tbt) or a biphenylalanine derivative
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a compound of formula (I) AA-AA-AA-X-Y-Z wherein, in any order, 2 of said AA (amino acid) moieties are cationic amino acids and 1 of said AA is an amino acid with a lipophilic R group, the R group having 14-27 non-hydrogen atoms; X is a N atom, which may be substituted by a branched or unbranched C1-C10 alkyl or aryl group which group may incorporate up to 2 heteroatoms selected from N, O and S; Y represents a group selected from -Ra-Rb-, -Ra-Rb-Rb- and -Rb-Rb-Ra- wherein Ra is C, O, S or N, and Rb is C; each of Ra and Rb may be substituted by C1-C4 alkyl groups or unsubstituted; and Z is a group comprising 1 to 3 cyclic groups each of 5 or 6 non-hydrogen atoms, 2 or more of the cyclic groups may be fused and one or more of the cyclic groups may be substituted; the Z moiety incorporates a maximum of 15 non-hydrogen atoms; and wherein the bond between Y and Z is a covalent bond between Ra or Rb of Y and a non-hydrogen atom of one of the cyclic groups of Z. The invention further relates to formulations containing these compounds and their uses in therapy, particularly as antimicrobial or antitumoural agents.